Literature DB >> 1718783

Site-directed mutagenesis of the N-terminal region of IGF binding protein 1; analysis of IGF binding capability.

A Brinkman1, D J Kortleve, A G Schuller, E C Zwarthoff, S L Drop.   

Abstract

To define domains involved in IGF binding 60 N-terminal amino acid residues of IGFBP-1 were deleted. This deletion resulted in loss of IGF binding suggesting that the N-terminus may enclose an IGF binding domain. However, most point mutations introduced in this region did not affect IGF binding. In contrast to Cys-34, only substitution of Cys-38 for a tyrosine residue abolished IGF binding. With the determination that all 18 cysteine residues are involved in disulphide bond formation our data suggest that, although not all cysteines contribute to the same extent, the ligand binding site may be spatially organized.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1718783     DOI: 10.1016/0014-5793(91)81298-m

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

Review 1.  What's new in the IGF-binding proteins?

Authors:  Steven A Rosenzweig
Journal:  Growth Horm IGF Res       Date:  2004-10       Impact factor: 2.372

2.  Hypoxia Increases IGFBP-1 Phosphorylation Mediated by mTOR Inhibition.

Authors:  Ian Damerill; Kyle K Biggar; Majida Abu Shehab; Shawn Shun-Cheng Li; Thomas Jansson; Madhulika B Gupta
Journal:  Mol Endocrinol       Date:  2015-12-29

3.  Zinc alters the kinetics of IGF-II binding to cell surface receptors and binding proteins.

Authors:  Robert H McCusker; Rebecca L Mateski; Jan Novakofski
Journal:  Endocrine       Date:  2003-08       Impact factor: 3.925

4.  IGFBP-1 in Cardiometabolic Pathophysiology-Insights From Loss-of-Function and Gain-of-Function Studies in Male Mice.

Authors:  Natalie J Haywood; Thomas A Slater; Michael Drozd; Nele Warmke; Connor Matthews; Paul A Cordell; Jessica Smith; Jethro Rainford; Harneet Cheema; Caitlyn Maher; Katherine I Bridge; Nadira Y Yuldasheva; Richard M Cubbon; Mark T Kearney; Stephen B Wheatcroft
Journal:  J Endocr Soc       Date:  2019-11-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.